Skip to content

BEPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BEPHAR

BE 0450.260.538
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€32,036
2024 · €35,207-€3,171
Equity
€165,161
2024 · €433,125-€267,964
Cash
€465,846
2024 · €432,720+€33,126
Balance sheet total
€466,425
2024 · €434,011+€32,414

Largest movements

2024 to 2025
Assets
  • Cash +€33,126

    up €33,126 (+7.7%), from €432,720 to €465,846

    mainly Other debts (+€300,000) and Net result for the year (+€32,036)

Equity and liabilities
  • Other debts +€300,000

    new in 2025: €300,000

  • Profit (loss) carried forward -€210,597

    down €210,597 (-88.0%), from €239,416 to €28,819

  • Reserves -€57,367

    down €57,367 (-82.2%), from €69,762 to €12,395

    of which Distributable reserves: -€57,367

Income statement
  • Gross operating margin -€3,965

    down €3,965 (-7.6%), from €51,856 to €47,891

  • Taxes -€974

    down €974 (-8.3%), from €11,736 to €10,762

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €35,207
Gross operating margin -€3,965
Other operating charges -€150
Financial charges -€30
Taxes +€974
Result 2025 €32,036
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€333,126
Investment €0
Financing -€300,000
Cash 2024 €432,720
Net result for the year +€32,036
Smaller working-capital items +€1,090
Other debts +€300,000
Contributions, distributions and other -€300,000
Cash 2025 €465,846
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €434,011 €466,425 +€32,414 +7.5%
Fixed assets 21/28 €341 €341 = 0.0%
Financial fixed assets 28 €341 €341 = 0.0%
Current assets 29/58 €433,670 €466,084 +€32,414 +7.5%
Amounts receivable within one year 40/41 €950 €238 -€712 -74.9%
Other amounts receivable 41 €950 €238 -€712 -74.9%
Cash at bank and in hand 54/58 €432,720 €465,846 +€33,126 +7.7%
Total equity and liabilities 10/49 €434,011 €466,425 +€32,414 +7.5%
Equity 10/15 €433,125 €165,161 -€267,964 -61.9%
Contributions 10/11 €123,947 €123,947 = 0.0%
Capital 10 €123,947 €123,947 = 0.0%
Issued capital 100 €123,947 €123,947 = 0.0%
Reserves 13 €69,762 €12,395 -€57,367 -82.2%
Non-distributable reserves 130/1 €12,395 €12,395 = 0.0%
Legal reserve 130 €12,395 €12,395 = 0.0%
Distributable reserves 133 €57,367 - -€57,367
Profit (loss) carried forward 14 €239,416 €28,819 -€210,597 -88.0%
Amounts payable 17/49 €886 €301,264 +€300,378 +33,903%
Amounts payable within one year 42/48 €886 €301,264 +€300,378 +33,903%
Trade debts 44 - €83 +€83
Suppliers 440/4 - €83 +€83
Taxes, remuneration and social security 45 €886 €1,181 +€295 +33.3%
Taxes 450/3 €886 €1,181 +€295 +33.3%
Other amounts payable 47/48 - €300,000 +€300,000
Other operating charges 640/8 €4,763 €4,913 +€150 +3.1%
Gross operating margin 9900 €51,856 €47,891 -€3,965 -7.6%
Operating profit (loss) 9901 €47,093 €42,978 -€4,115 -8.7%
Financial charges 65/66B €150 €180 +€30 +20.0%
Recurring financial charges 65 €150 €180 +€30 +20.0%
Profit (loss) for the period before taxes 9903 €46,943 €42,798 -€4,145 -8.8%
Income taxes 67/77 €11,736 €10,762 -€974 -8.3%
Profit (loss) for the period 9904 €35,207 €32,036 -€3,171 -9.0%
Profit (loss) for the period to be appropriated 9905 €35,207 €32,036 -€3,171 -9.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.